Clinical Trials
760 trialsCAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors
Carisma Therapeutics Inc
Phase I Trial: T4 Immunotherapy of Head and Neck Cancer
King's College London
GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results
Suzhou Genhouse Bio Co., Ltd.
Combined Anti-IL6R and Anticoagulation Therapy in Advanced NPC Patients
Affiliated Hospital of Nantong University
TOETVA
Instituto do Cancer do Estado de São Paulo
Assessment of (Chemo)RT-related Dysphagia in HNC Patients Based on Cough-related Acoustic Features
Jules Bordet Institute
Adding PD-1 Inhibitor to Neoadjuvant and Adjuvant for NPC
Jiangxi Provincial Cancer Hospital
Use of PET-MR in Head and Neck Cancer Patients - Diagnostic and Therapeutic Applications
Sheffield Teaching Hospitals NHS Foundation Trust
Compare the Effects of NLSCP and Interactive ICT Supported HAP on Differentiate Diagnosed Thyroid Cancer Patients
National Taiwan University Hospital
Radiofrequency Ablation in TIR3A Nodules With Negative Genetic Evaluation
Istituto Auxologico Italiano
Study to Evaluate Safety and Efficacy of TJ107 Combine With PD-1 in Patients With Solid Tumors
TJ Biopharma Co., Ltd.
Sintilimab Combination Therapy Plus IMRT in Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital
Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal Cancer.
Taipei Veterans General Hospital, Taiwan
Early Feeding After Oral Cavity Reconstruction
Icahn School of Medicine at Mount Sinai
HIFU Treatment of Benign Thyroid Nodules
Theraclion
The Protection of Thyroid Function in IMRT for Nasopharyngeal Carcinoma
Jiangxi Provincial Cancer Hospital
DIPPER
Sun Yat-sen University
Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
NGM Biopharmaceuticals, Inc
OPEN
Irish Research Radiation Oncology Group
Palbociclib With Cetuximab and IMRT for Locally Advanced Squamous Cell Carcinoma
Mahidol University
Treatment Efficacy and Safety of Low-dose Radioiodine Ablation for Intermediate-risk Differentiated Thyroid Carcinoma
Zhujiang Hospital
RADIOCARIES
University of Milan
MK-3475-E90
Wellmarker Bio
KSD-101 Therapy for EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical Trial
Kousai Bio Co., Ltd.
Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms
R-Pharm
Oral Potentially Malignant Disorders: Comparison Between Surgical Treatment and Wait and See Approach
University of Milan
Camrelizumab and Chemotherapy Combined With Endoscopic Surgery for Recurrent Nasopharyngeal Carcinoma
Eye & ENT Hospital of Fudan University
Identification of Oral Lesions Through an Autofluorescence System
Federico II University
Acupuncture for Prevention and Treatment of Oral-related Complications Caused by Radiotherapy for Head and Neck Cancer
West China Hospital
Photobiomodulation for the Prevention of Radiation Induced Oral Mucositis
Ottawa Hospital Research Institute
Efficacy and Safety of Toripalimab Combined With AP-induced Chemotherapy Followed in Non-metastatic IVB Hypopharyngeal Cancer
Chinese PLA General Hospital
VUBAR
Universitair Ziekenhuis Brussel
CRISP
Centre hospitalier de l'Université de Montréal (CHUM)
Efficacy and Safety of TORS for SCCA
University of Virginia
Bacterial Decolonization to Prevent Radiation-induced Oral Mucositis
Jiangxi Provincial Cancer Hospital
Combining RT With Immunotherapy and Chemotherapy in Metastatic Nasopharyngeal Carcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor
HRYZ Biotech Co.
Neoadjuvant Tislelizumab Plus Chemotherapy for Resectable Locally-advanced Head and Neck Squamous Cell Carcinoma
Tongji Hospital
PARVA
University of Virginia
Concomitant Immune Check Point Inhibitor With Radiochemotherapy in Head And Neck Cancer
Kuwait Cancer Control Center
Nivolumab and Ipilimumab in Treating Patients With Metastatic/Recurrent ACC of All Sites and Non-ACC Salivary Gland Cancer
Northwestern University
Study of Docetaxel and Cisplatin Combined With Nimotuzumab As First-Line Treatment in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma
Sun Yat-sen University
A Phase II Study of Cemiplimab and ISA101b in Patients With Recurrent/Metastatic HPV16 Positive OPC
ISA Pharmaceuticals
CLAWED
Sixth Affiliated Hospital, Sun Yat-sen University
Study of the Role of Oncostatin M in Head and Neck Squamous Cell Carcinoma
Poitiers University Hospital
Study of Post-Op Adjuvant Concurrent Chemo-RT With or Without Nimotuzumab for Head & Neck Cancer
National Cancer Centre, Singapore
RemImazolam Besylate for ICU-sedation in Patients With Mechanical Ventilation After Oral and Maxillofacial Surgery
Nanfang Hospital, Southern Medical University
PECS II Block and Single Port Robot-assisted Transaxillary Thyroidectomy
Seoul St. Mary's Hospital
Patient Education Videos to Improve Patients' Experience During Radiotherapy Treatment: a National Project
University Hospital, Ghent
A Randomized Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC
ISA Pharmaceuticals